We are live on ! Find out more

1,436 hedge funds and large institutions have $90.4B invested in Amgen in 2016 Q1 according to their latest regulatory filings, with 97 funds opening new positions, 597 increasing their positions, 501 reducing their positions, and 100 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 597 | Existing positions reduced: 501

0.56% less ownership

Funds ownership: 80.87%80.32% (-0.56%)

3% less first-time investments, than exits

New positions opened: 97 | Existing positions closed: 100

1% less funds holding

Funds holding: 1,4551,436 (-19)

8% less capital invested

Capital invested by funds: $98.6B → $90.4B (-$8.1B)

17% less call options, than puts

Call options by funds: $752M | Put options by funds: $911M

24% less funds holding in top 10

Funds holding in top 10: 11285 (-27)

Holders
1,436
Holders Change
-19
Holders Change %
-1.31%
% of All Funds
38.12%
Holding in Top 10
85
Holding in Top 10 Change
-27
Holding in Top 10 Change %
-24.11%
% of All Funds
2.26%
New
97
Increased
597
Reduced
501
Closed
100
Calls
$752M
Puts
$911M
Net Calls
-$159M
Net Calls Change
-$197M

AMGN Hedge Fund Activity: Q1 2016 in Review

1,436 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q1 2016, worth a combined $90.4B — down 8.2% from $98.6B a quarter earlier.

Sellers outnumbered buyers: 100 funds closed out of AMGN and 97 opened new positions — a net loss of 3 holders — while 501 trimmed existing stakes and 597 added.

The largest buyer was Wellington Management Group, adding an estimated $277M. The largest seller was Third Point, cutting an estimated $898M.

  • 1,436 institutional investors held Amgen (AMGN) as of Q1 2016, down from 1,455 in Q4 2015.
  • Funds reported $90.4B of Amgen stock for Q1 2016, down 8.2% quarter-over-quarter.
  • 97 funds opened new Amgen positions in Q1 2016 and 100 closed out, a net change of -3 holders.
  • The largest Amgen buyer in Q1 2016 was Wellington Management Group, an estimated $277M added.
  • The largest Amgen seller in Q1 2016 was Third Point, an estimated $898M sold.

Based on aggregated 13F filings for Q1 2016.